Brief: Zhuhai Rundu Pharmaceutical's Client To Recall Four Products Containing Valsartan
03/08/2018 13:55
Aug 3 (Reuters) - Zhuhai Rundu Pharmaceutical Co Ltd
002923.SZ :
* SAYS ITS CLIENT STANDARD CHEMICAL & PHARMACEUTICAL
1720.TW TO
HALT PRODUCTION AND RECALL FOUR PRODUCTS CONTAINING VALSARTAN
SUPPLIED BY THE COMPANY
* SAYS IT IS IN NEGOTIATION WITH STANDARD CHEMICAL &
PHARMACEUTICAL TO MINIMIZE THE IMPACT OF PRODUCT RECALL
Source text in Chinese: https://bit.ly/2na6myU
Further company coverage: 002923.SZ 1720.TW
(Reporting by Hong Kong newsroom)
((twinnie.siu@thomsonreuters.com; 852-2841 5763; Reuters
Messaging: twinnie.siu.thomsonreuters.com@reuters.net))
Recent news on Standard Chem & Pharm
See all newsBrief: Zhuhai Rundu Pharmaceutical Says Has Never Sold Valsartan Material To S.Korea
Brief: Zhuhai Rundu Pharmaceutical's Client To Recall Four Products Containing Valsartan
Brief: Standard Chemical & Pharmaceutical to pay annual cash dividend as T$1.6/share for 2017
Brief: Standard Chemical & Pharmaceutical to pay cash dividend of T$1.5 per share for 2016
Brief: Standard Chemical & Pharmaceutical to pay 2015 dividend on Aug. 31